Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1608 per ML under NDC 67877065861. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
2.5 mg/mL
Manufacturer
Ascend Laboratories, LLCNDC
67877065861
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA213039On Market Since
5/7/2021
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 73.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1608 per ML |
|---|---|
| All-time high | $0.6119 (Dec 15, 2021) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.2387 |
| Average price | $0.2878 |
| Largest weekly change | +35.6% (Nov 17, 2021) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Ascend Laboratories, LLC, is $0.1608 per ML (NDC 67877065861), effective Jun 24, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 73.1%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Aug 4, 2021, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $0.6119 (Dec 15, 2021), with a median of $0.2387 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 2.5 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 67877065861) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification